[Form 4] Olaplex Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Olaplex Holdings director Pamela J. Edwards received a grant of 110,294 restricted stock units (RSUs) on 08/12/2025. Each RSU represents the conditional right to one share of Olaplex common stock and was reported as issued at a $0 price. The RSUs are scheduled to vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to Ms. Edwards' continued service through that vesting date. Following the reported transaction, the reporting person beneficially owns 110,294 shares directly. The form was submitted via attorney-in-fact signature on 08/14/2025.

Positive

• Time‑based retention award: 110,294 RSUs align the director’s interests with long‑term shareholder value by vesting at the 2026 annual meeting

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received a sizable time‑based equity grant that vests at next annual meeting; routine compensation, limited immediate market impact.

The 110,294 RSU award is a non‑cash, time‑based retention instrument payable in one share per RSU at vesting. Because the grant vests only upon continued service through the 2026 annual meeting, there is no immediate share issuance at the transaction date and no cash proceeds to the reporting person. From an investor perspective this is a routine director compensation action and typically has neutral near‑term effects on operating results. Materiality depends on company size and total shares outstanding, which are not provided in this filing.

Corporate Governance Expert

TL;DR: This is a standard retention/compensation RSU grant to a director with a single vesting event tied to continued service.

The award structure—full vesting at the 2026 annual meeting—aligns executive/director incentives with ongoing service and shareholder timelines. The filing indicates direct beneficial ownership and compliance with Section 16 reporting via an attorney‑in‑fact signature. The disclosure lacks details on grant approval authority or whether this grant is part of a routine schedule, so governance implications are typical rather than exceptional based on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Edwards Pamela J

(Last) (First) (Middle)

C/O OLAPLEX HOLDINGS, INC.

432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)

NEW YORK NY 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		A		110,294(1)	A	$0	110,294	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney.

	/s/ John Duffy, attorney-in-fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Pamela J. Edwards report on Form 4 for OLPX?

The Form 4 reports a grant of 110,294 restricted stock units (RSUs) to Pamela J. Edwards on 08/12/2025.

When do the RSUs granted to Pamela J. Edwards vest?

The RSUs are scheduled to vest in full on the date of Olaplex’s 2026 Annual Meeting of Stockholders, subject to continued service.

Was any cash paid for the RSUs reported in this filing?

No cash was paid; the transaction is reported with a $0 price, indicating an equity grant rather than a purchase.

How many shares does Pamela J. Edwards beneficially own following the reported transaction?

Following the reported transaction, the filing shows 110,294 shares beneficially owned directly.

Who signed the Form 4 filing for Pamela J. Edwards?

The Form 4 was signed by John Duffy, attorney‑in‑fact on behalf of the reporting person on 08/14/2025.